Cyclophosphamide
Stage II Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Stage II Renal Pelvis Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Epirubicin Alliance for Clinical Trials in Oncology | Phase 3 | B |
Pembrolizumab Alliance for Clinical Trials in Oncology | Phase 3 | B |
Tivozanib Alliance for Clinical Trials in Oncology | Phase 3 | B |
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →